Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Polycystic Ovary Syndrome 1Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Frailty 1Fanconi Anemia 1Carcinoma, Squamous Cell 1

Interventions

fludarabine phosphate 4Cyclophosphamide 4Busulfan 3Antilymphocyte Serum 3fludarabine 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2thymoglobulin 1sargramostim 1prexasertib 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Quercetin 1Mycophenolic Acid 1Melphalan 1Dietary Supplements 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fanconi Anemia × Quercetin × Clear all
NCT03476330 2026-04-20

Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
48 enrolled 7 charts
Classical hematology

Carcinoma, Squamous Cell, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡